Multiple Myeloma Molecular Monitoring Study
Multiple Myeloma Molecular Monitoring Study
Active, not recruiting · NCT03421132 · Registry updated 2025-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multiple Myeloma Molecular Monitoring Study | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Not stated | 2025-06-29 | NCT03421132 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Horizon Health Network | 9 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Buland Mangukia | Hamilton | Canada | 1 |
| CancerCare Manitoba | Winnipeg | Canada | 98 |
| Cross Cancer Institute | Edmonton | Canada | 146 |
| McGill University Health Centre | Montreal | Canada | 69 |
| Princess Margaret Cancer Centre | Toronto | Canada | 9 |
| Queen Elizabeth II Health Sciences Centre | Halifax | Canada | 12 |
| Saint John Regional Hospital (Horizon Health Network) | Saint John | Canada | 1 |
| Tom Baker Cancer Centre | Calgary | Canada | 29 |
| Vancouver General Hospital | Vancouver | Canada | 53 |